CAS 294646-77-8
:1-Butanol,2-[[9-(1-methylethyl)-6-[[[4-(2-pyridinyl)phenyl]methyl]amino]-9H-purin-2-yl]amino]-, (2R)-
- CR8
1-Butanol, 2-[[9-(1-methylethyl)-6-[[[4-(2-pyridinyl)phenyl]methyl]amino]-9H-purin-2-yl]amino]-, (2R)-
CAS:Formel:C24H29N7OReinheit:99%Farbe und Form:SolidMolekulargewicht:431.5334(R)-CR8
CAS:(R)-CR8 ((R)-Isomer) is a potent and selective CDK inhibitor.
Formel:C24H29N7OReinheit:98.41%Farbe und Form:SolidMolekulargewicht:431.53(R)-2-((9-Isopropyl-6-((4-(Pyridin-2-yl)Benzyl)Amino)-9H-Purin-2-yl)Amino)Butan-1-ol
CAS:(R)-2-((9-Isopropyl-6-((4-(Pyridin-2-yl)Benzyl)Amino)-9H-Purin-2-yl)Amino)Butan-1-olReinheit:99%Molekulargewicht:431.53g/molCR8, (R)-Isomer
CAS:Kontrolliertes ProduktFormel:C24H29N7OFarbe und Form:NeatMolekulargewicht:431.533CR8, (R)-Isomer
CAS:CR8, (R)-isomer is a metabolite of sodium carbonate that has been shown to have neutralizing effects. It binds to the form bound to the polymerase chain and inhibits metabolic disorders by regulating the pH balance. CR8, (R)-isomer has been shown to be safe and effective in the treatment of neurological disorders that are caused by neuronal death. The antimicrobial property of this compound is due to its ability to inhibit bacterial growth through membrane interactions. This drug also has been shown to block PD-L1, which may help treat malignant tumors.
CR8, (R)-isomer is a member of the class of compounds called pyrazolyloxyphenylboronic acid derivatives, which are used as antimicrobial agents. These compounds contain a hydroxyl group that allows them to bind with membranes in bacteria and disrupt cellular function. They also possess an aromatic ring that is able to react with amino groups on proteins at the lipid-water interfaceFormel:C24H29N7OReinheit:Min. 95%Molekulargewicht:431.53 g/mol






